Ormaplatin resistance is associated with decreased accumulation of its platinum (II) analogue, dichloro(D,L-trans)1,2-diaminocyclohexaneplatinum (II).

Ormaplatin (also known as tetraplatin) is a platinum-containing analogue which has recently undergone clinical trials. Ormaplatin may undergo conversion to dichloro(D,L-trans)-1,2-diaminocyclohexaneplatinum(II) [P1Cl2(trans-dach)]. The cisplatin-resistant murine lymphoma cell lines E8 and E5, were f...

Descripción completa

Detalles Bibliográficos
Autores principales: Rischin, D., Ling, V.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074663/
https://www.ncbi.nlm.nih.gov/pubmed/8761375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074663/
https://www.ncbi.nlm.nih.gov/pubmed/8761375

Ejemplares similares